Evidence map›Paper›PMID 28484347›Full record

ArticleMateria socio-medica2017

T-lymphocyte Subsets as a Prognostic Factor in a Clinical Course of Chickenpox.

Rusmir Baljic, Hadzan Konjo, Dzenana Hrustemovic, Belma Gazibera, Amela Katica, Mirsada Hukic

Open access · greenAbstract read
In one paragraph

Article in Materia socio-medica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rusmir BaljicClinic for Infectious Disease, Clinical Center University of Sarajevo, Bosnia-Herzegovina.
Hadzan KonjoClinic for Orthopedics and Traumatology, Clinical Center University of Sarajevo, Bosnia-Herzegovina.
Dzenana HrustemovicClinic for Cardiology, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Belma GaziberaClinic for Infectious Disease, Clinical Center University of Sarajevo, Bosnia-Herzegovina.
Amela KaticaClinic for Anesthesiology and Reanimation, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Mirsada HukicBurch International University, Sarajevo, Bosnia-Herzegovina.
University of Sarajevo · BAInternational Burch University · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate possible prognostic values of CD4+, CD8+ T-lymphocytes, CD4/CD8 ratio to clinical course of chickenpox in immunocompetent hosts. MATERIALS AND

methodsWe performed a prospective study which included 69 immunocompetent patients with chickenpox who were addmited to Clinic for infectious disease, Clinical Center University of Sarajevo, in a 18 month period. All patients were divided into two groups depending on clinical presentation on admission. Patients with mild clinical form were dedicated to "outpatient" group, and patients with moderate, severe or life-threatening clinical forms were dedicated to "hospitalized" group. Also 30 healthy volunteers are included in study as a control group. We analyzed values of CD4+, CD8+ percentage, CD4/CD8 ratio with comparison to clinical course of chickenpox. All specimens were taken in acute phase of illness.

resultsValues of CD4+ percentage were significantly declined in a group of hospitalized patients, compared to group of outpatients and control group. Values of CD8+ percentage were higher in a group of hospitalized patients, while CD4/CD8 values were lower in comparison to a group of outpatients and control group.

conclusionWe found significant correlation between these parameters and clinical course of chickenpox.

Indexed as

Chickenpoxprognostic factorsT-lymphocyte

Identifiers

PMID28484347
PMCPMC5402378
OpenAlexW2602383544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.